Takeda Pharmaceutical Company Limited Logo

Takeda Pharmaceutical Company Limited

A global, R&D-driven biopharmaceutical company discovering and delivering treatments.

4502 | T

Overview

Corporate Details

ISIN(s):
JP3463000004 (+1 more)
LEI:
Country:
Japan
Address:
大阪市中央区道修町四丁目1番1号

Description

Takeda Pharmaceutical Company Limited is a global, patient-focused, and R&D-driven biopharmaceutical company dedicated to discovering and delivering life-transforming treatments. The company's mission is to provide better health for people and a brighter future for the world. Its core therapeutic areas of focus include oncology, rare diseases, neuroscience, and gastroenterology. Takeda also invests significantly in Plasma-Derived Therapies and Vaccines. The company's operations encompass the entire pharmaceutical value chain, from translating science into highly innovative medicines through research and development to manufacturing, sales, and marketing on a global scale.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2019-06-27 09:17
有価証券報告書-第142期(平成30年4月1日-平成31年3月31日)
Japanese ZIP 2.7 MB
2019-02-14 05:33
四半期報告書-第142期第3四半期(2018/10/01-2018/12/31)
Japanese ZIP 398.1 KB
2018-11-08 05:01
四半期報告書-第142期第2四半期(2018/07/01-2018/09/30)
Japanese ZIP 363.4 KB
2018-08-10 08:20
四半期報告書-第142期第1四半期(2018/04/01-2018/06/30)
Japanese ZIP 328.5 KB
2018-06-28 09:31
有価証券報告書-第141期(平成29年4月1日-平成30年3月31日)
Japanese ZIP 1.9 MB
2018-02-09 05:02
四半期報告書-第141期第3四半期(2017/10/01-2017/12/31)
Japanese ZIP 377.0 KB
2017-11-10 06:28
四半期報告書-第141期第2四半期(2017/07/01-2017/09/30)
Japanese ZIP 331.3 KB
2017-08-09 05:31
四半期報告書-第141期第1四半期(2017/04/01-2017/06/30)
Japanese ZIP 280.3 KB
2017-06-29 02:33
有価証券報告書-第140期(2016/04/01-2017/03/31)
Japanese ZIP 1.9 MB
2017-02-10 05:04
四半期報告書-第140期第3四半期(2016/10/01-2016/12/31)
Japanese ZIP 380.5 KB
2016-11-11 04:46
四半期報告書-第140期第2四半期(2016/07/01-2016/09/30)
Japanese ZIP 334.7 KB
2016-08-10 05:51
四半期報告書-第140期第1四半期(2016/04/01-2016/06/30)
Japanese ZIP 282.6 KB
2016-06-29 08:04
有価証券報告書-第139期(2015/04/01-2016/03/31)
Japanese ZIP 1.7 MB
2016-02-10 06:45
四半期報告書-第139期第3四半期(2015/10/01-2015/12/31)
Japanese ZIP 325.1 KB
2015-11-12 04:43
四半期報告書-第139期第2四半期(2015/07/01-2015/09/30)
Japanese ZIP 301.4 KB

Automate Your Workflow. Get a real-time feed of all Takeda Pharmaceutical Company Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Takeda Pharmaceutical Company Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Takeda Pharmaceutical Company Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.